HR 2179 United States House · 117th Congress

Affordable Insulin for the COVID–19 Emergency Act

Summary

Affordable Insulin for the COVID-19 Emergency Act This bill eliminates cost-sharing under the Medicare prescription drug benefit and Medicare Advantage for insulin and associated medical supplies during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). The bill also allows beneficiaries to receive their insulin and supplies via mail order during the emergency period.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Mar 2021

Committee Review

Floor Vote

President

Introduced Mar 23, 2021 Last action Mar 24, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 24, 2021

Committee

Referred to the Subcommittee on Health.

lower

Mar 23, 2021

Committee

Referred to the Subcommittee on Health.

lower

Mar 23, 2021

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Mar 23, 2021

Introduced

Introduced in House

lower

1 primary · 42 co-sponsors